Therapy News and Research

RSS

Discovery Labs submits IND application to start AEROSURF phase 2 clinical program

Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, today announced that it has submitted an investigational new drug application to the U.S. Food and Drug Administration to initiate its AEROSURF phase 2 clinical program.

17 Oct 2013

AmpliPhi, University of Leicester partner to develop novel bacteriophage therapy against C. difficile

AmpliPhi BioSciences Corporation, the leader in the development of bacteriophage-based antibacterial therapies to treat antibiotic resistant infections, announces it has entered into Collaboration and License Agreements with UK-based University of Leicester to develop a novel bacteriophage therapy targeting Clostridium difficile, a serious gastrointestinal infection for which new treatments are urgently required.

17 Oct 2013

Review article looks at recent research about insomnia among American soldiers

Various behavioral treatment options are helping to treat the sleeplessness experienced by one in every two American soldiers who have been deployed in recent military operations. So says Dr. Adam Bramoweth of the Department of Veterans Affairs Pittsburgh Healthcare System, and Dr. Anne Germain of the University of Pittsburgh School of Medicine in the US.

17 Oct 2013

Good news: Knowing risk early, women can take action to prevent osteoporosis

On World Osteoporosis Day, October 20, the International Osteoporosis Foundation (IOF) is calling for women to take action now to protect their bone health. Broken bones due to osteoporosis often result in pain, immobility and loss of quality of life as well as early death.

17 Oct 2013

Overutilization of radioactive iodine to treat PTC leads to worse access to health care

The American Thyroid Association (ATA) recommends against the routine use of radioactive iodine after surgery to remove the thyroid in patients with low-risk papillary thyroid cancer (PTC).

17 Oct 2013

CardioFocus completes HeartLight EAS pivotal trial enrollment for symptomatic paroxysmal AF

CardioFocus, Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation, today announced that it has concluded enrollment of its U.S. pivotal trial evaluating the HeartLight system, for the treatment of symptomatic paroxysmal AF.

17 Oct 2013

Study shows that brains process pain of villains more than pain of people we like

Counterintuitive findings from a new USC study show that the part of the brain that is associated with empathizing with the pain of others is activated more strongly by watching the suffering of hateful people as opposed to likable people.

17 Oct 2013

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.

16 Oct 2013

Proper sleep helps maintain a healthy lifestyle

Three new studies show just how critical it is for adults to seek treatment for a sleep illness and aim for seven to nine hours of sleep each night in order to maintain a healthy lifestyle.

16 Oct 2013

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

The Detroit Lions and Josephine Ford Cancer Institute, Michigan's largest provider of adult cancer care, have created a unique partnership with the goal to raise $15 million during the next three years for cancer research in metro Detroit.

16 Oct 2013

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it will collaborate with a pharmaceutical company to evaluate Trovagene's proprietary, urine-based, cell-free DNA technology for the detection of certain epidermal growth factor receptor mutations associated with lung cancer.

16 Oct 2013

Get With The Guidelines--Stroke hospitals provide recommended guideline-based care for patients

Award-winning Get With The Guidelines--Stroke hospitals are more likely than Primary Stroke Center certified hospitals to provide all the recommended guideline-based care for patients, according to new research in the Journal of the American Heart Association.

16 Oct 2013

Evidence less consistent for high blood sugar, insulin treatment and oral agents

Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University was senior author of a consensus statement from the American Association of Clinical Endocrinologists on diabetes and cancer, which was just published in Endocrinology Practice.

16 Oct 2013

New type of antibiotic kills multidrug-resistant germ common to health care settings

A new type of antibiotic called a PPMO, which works by blocking genes essential for bacterial reproduction, successfully killed a multidrug-resistant germ common to health care settings, UT Southwestern Medical Center researchers report.

16 Oct 2013

Brain damage treatment could be as close as the wardrobe

For those with brain damage or neurological disorders - such as MS or Parkinson's - treatment could be as close as the wardrobe.

16 Oct 2013

Common catalyst cerium oxide opens door to nanochemistry for medicine

Scientists at Rice University are enhancing the natural antioxidant properties of an element found in a car's catalytic converter to make it useful for medical applications.

16 Oct 2013

Researchers test ATR-101 compound in clinical trial for adrenal cancer

One of the most challenging cancers to treat is also one of the rarest, which only adds to the challenge of finding potential new therapies.

16 Oct 2013

Ghrelin hormone released during chronic stress may predispose people to PTSD

About a dozen years ago, scientists discovered that a hormone called ghrelin enhances appetite. Dubbed the "hunger hormone," ghrelin was quickly targeted by drug companies seeking treatments for obesity - none of which have yet panned out.

16 Oct 2013

Breast cancer patients receiving nerve block with general anesthesia have less cancer recurrence

Breast cancer patients who received the combination of a nerve block with general anesthesia for their breast cancer surgery had less cancer recurrence and were three times less likely to die than those who received only general anesthesia, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

16 Oct 2013

Three universities receive $2M grant to develop Stroke Regional Coordinating Center

Stroke is the second leading cause of death in Los Angeles County and the fourth in the U.S. In order to cut those numbers, it's imperative that new treatments be developed and refined for stroke prevention, acute therapy and recovery after stroke.

16 Oct 2013

Therapy News and Research

Discovery Labs submits IND application to start AEROSURF phase 2 clinical program

AmpliPhi, University of Leicester partner to develop novel bacteriophage therapy against C. difficile

Review article looks at recent research about insomnia among American soldiers

Good news: Knowing risk early, women can take action to prevent osteoporosis

Overutilization of radioactive iodine to treat PTC leads to worse access to health care

CardioFocus completes HeartLight EAS pivotal trial enrollment for symptomatic paroxysmal AF

Study shows that brains process pain of villains more than pain of people we like

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Proper sleep helps maintain a healthy lifestyle

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

Get With The Guidelines--Stroke hospitals provide recommended guideline-based care for patients

Evidence less consistent for high blood sugar, insulin treatment and oral agents

New type of antibiotic kills multidrug-resistant germ common to health care settings

Brain damage treatment could be as close as the wardrobe

Common catalyst cerium oxide opens door to nanochemistry for medicine

Researchers test ATR-101 compound in clinical trial for adrenal cancer

Ghrelin hormone released during chronic stress may predispose people to PTSD

Breast cancer patients receiving nerve block with general anesthesia have less cancer recurrence

Three universities receive $2M grant to develop Stroke Regional Coordinating Center

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News